Ikaria Bioscience Pty Ltd
Clinical trials sponsored by Ikaria Bioscience Pty Ltd, explained in plain language.
-
New combo weight loss pill enters human testing
Disease control Recruiting nowThis study tests a new drug called RN3161, alone and together with an existing weight loss drug (tirzepatide), in adults with overweight or obesity. The goal is to check safety, how the body processes the drug, and its effect on body weight. About 104 people will take part, inclu…
Phase: PHASE1, PHASE2 • Sponsor: Ikaria Bioscience Pty Ltd • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New cholesterol drug RN5681 enters first human tests
Disease control Recruiting nowThis early-stage study tests a single dose of the experimental drug RN5681 in 60 healthy adults with high cholesterol. The main goal is to check safety and how the body processes the drug. Researchers will also measure changes in cholesterol levels over time. This is a first step…
Phase: PHASE1 • Sponsor: Ikaria Bioscience Pty Ltd • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC